We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
Join our healthcare community
Explore Medicare coverage for WATCHMAN surgery, a life-changing procedure for AFib patients at high stroke risk who can't take blood thinners. Learn about eligibility, costs, Medicare Parts A, B, C, D, and what to expect from the shared decision-making process. Get answers to common FAQs about this vital stroke prevention option.
Atrial Fibrillation (AFib) is the most common type of heart arrhythmia, affecting millions of Americans, particularly as they age. For many, AFib significantly increases the risk of stroke, a debilitating and potentially fatal event. While blood thinners (anticoagulants) are highly effective in preventing AFib-related strokes, they come with their own set of challenges, primarily an increased risk of bleeding. For individuals who cannot safely take long-term oral anticoagulants, the WATCHMAN FLX™ Left Atrial Appendage Closure (LAAC) device offers a life-changing alternative. But as with any advanced medical procedure, a crucial question arises: Does Medicare cover WATCHMAN surgery?
Navigating healthcare coverage can be complex, especially for specialized procedures like the WATCHMAN implant. This comprehensive guide aims to demystify Medicare's stance on WATCHMAN surgery, outlining the eligibility criteria, what different parts of Medicare cover, potential out-of-pocket costs, and what you need to know to make informed decisions about your heart health.
Atrial Fibrillation is an irregular and often rapid heart rate that can lead to poor blood flow to the body. During AFib, the heart's two upper chambers (the atria) beat chaotically and irregularly, out of sync with the two lower chambers (the ventricles). This irregular rhythm can cause blood to pool in the atria, increasing the risk of clot formation.
The LAA is a small, ear-shaped pouch located in the muscular wall of the left atrium. While its exact function is not fully understood, it is known to be a common site for blood clot formation in people with non-valvular AFib. When the atria fibrillate, blood doesn't flow smoothly through the LAA, allowing it to stagnate and form clots. If a clot breaks loose, it can travel to the brain, causing an ischemic stroke.
For decades, the primary method of stroke prevention in AFib patients has been oral anticoagulation therapy, commonly known as blood thinners. These medications, such as warfarin (Coumadin) or newer direct oral anticoagulants (DOACs) like apixaban (Eliquis), rivaroxaban (Xarelto), dabigatran (Pradaxa), and edoxaban (Savaysa), work by reducing the blood's ability to clot. While highly effective, blood thinners carry a significant risk of bleeding, which can range from minor nosebleeds and bruising to severe and life-threatening internal hemorrhages, particularly in the brain or gastrointestinal tract.
Many patients are unable to tolerate long-term oral anticoagulation due to:
For patients who fit the criteria of having non-valvular AFib and a high risk of stroke but cannot take long-term oral anticoagulants, the WATCHMAN FLX™ device offers a crucial alternative. The WATCHMAN device is a permanent implant designed to close off the LAA, thereby preventing blood clots formed in this area from entering the bloodstream and causing a stroke.
The WATCHMAN procedure is a minimally invasive, catheter-based procedure performed in a hospital setting. Here's a general overview:
The procedure typically takes about an hour, and patients usually stay in the hospital for one to two days for observation. Over time, heart tissue grows over the device, permanently sealing off the LAA.
The primary benefit of the WATCHMAN device is to reduce the risk of stroke in eligible AFib patients without the long-term need for oral anticoagulants. This significantly lowers the risk of bleeding complications associated with blood thinners, improving the patient's quality of life and safety.
Like any medical procedure, the WATCHMAN implant carries potential risks, including:
It's crucial for patients to have a thorough discussion with their healthcare team about the potential benefits and risks specific to their situation.
Before diving into WATCHMAN coverage, it's essential to understand the basics of Medicare. Medicare is a federal health insurance program primarily for people aged 65 or older, but also for certain younger people with disabilities and people with End-Stage Renal Disease (ESRD) or Amyotrophic Lateral Sclerosis (ALS).
The good news is, yes, Medicare does cover WATCHMAN surgery for eligible beneficiaries. The Centers for Medicare & Medicaid Services (CMS) established a National Coverage Determination (NCD) for Left Atrial Appendage Closure (LAAC) devices, including the WATCHMAN, back in 2016 (NCD 20.34). This NCD specifies the conditions under which Medicare will cover the procedure.
To be covered by Medicare for a WATCHMAN device, patients must meet specific criteria. These criteria are designed to ensure that the procedure is performed on individuals who will benefit most and for whom the risks of long-term oral anticoagulation outweigh the risks of the procedure itself.
The patient must:
The NCD also specifies requirements for the facilities and physicians performing the procedure to ensure patient safety and optimal outcomes:
Understanding which part of Medicare covers which aspect of your WATCHMAN surgery is crucial for anticipating costs.
Once you've met your Part B deductible, Medicare generally pays 80% of the Medicare-approved amount for these services, and you are responsible for the remaining 20% coinsurance.
Even with Medicare coverage, you can expect to have some out-of-pocket expenses. These typically include:
If you have Original Medicare (Parts A and B) and a Medigap policy, your Medigap plan can help cover some or all of your out-of-pocket costs, such as Part A and Part B deductibles, coinsurance, and copayments. The extent of coverage depends on the specific Medigap plan you choose.
For individuals with limited income and resources, there may be additional programs available to help with healthcare costs, such as Medicare Savings Programs or Extra Help for prescription drug costs. It's advisable to explore these options if you believe you might qualify.
As mentioned, the NCD for WATCHMAN surgery specifically mandates a shared decision-making process. This isn't just a formality; it's a crucial step to ensure that you, as the patient, are fully informed and actively involved in the decision regarding your stroke prevention strategy.
During this process, you should expect:
This process empowers you to make an informed choice that aligns with your health goals and personal circumstances, ensuring that the WATCHMAN procedure, if chosen, is truly the best option for you.
If you have Atrial Fibrillation or suspect you might, it's crucial to consult with a healthcare professional, specifically a cardiologist or electrophysiologist. Consider seeing a doctor if:
Your doctor can assess your individual risk factors, evaluate your suitability for different treatments, and guide you through the shared decision-making process for stroke prevention.
A: No. Since the establishment of the National Coverage Determination (NCD 20.34) in 2016, the WATCHMAN device and procedure are considered medically necessary and covered by Medicare for eligible beneficiaries who meet the specific criteria outlined in the NCD.
A: The WATCHMAN device is designed to be a permanent implant. Once implanted and the heart tissue grows over it, it remains in place for life, continuously sealing off the LAA.
A: Immediately after the procedure, you will typically need to take blood thinners (usually warfarin or a DOAC) and aspirin for about 45 days. After this period, if your LAA is confirmed to be sealed, your doctor will likely transition you to a regimen of dual antiplatelet therapy (aspirin and clopidogrel) for several months, followed by long-term aspirin therapy alone. The specific post-procedure medication regimen can vary based on individual patient factors and physician discretion.
A: The current Medicare NCD for WATCHMAN specifies that the patient must have non-valvular AFib. This means AFib not caused by certain heart valve issues like moderate to severe mitral stenosis or a mechanical heart valve. If you have valvular AFib, your doctor will discuss alternative stroke prevention strategies.
A: If your Medicare Advantage plan denies coverage, you have the right to appeal the decision. You can usually appeal directly to your plan, and if denied again, you can appeal to an independent review organization. It's crucial to understand your plan's appeal process and seek assistance from your healthcare provider or a Medicare advocacy group if needed.
A: You can find the official NCD 20.34 for Left Atrial Appendage Closure (LAAC) devices on the Centers for Medicare & Medicaid Services (CMS) website. Searching for

Experiencing blurry or cloudy vision due to aging can significantly lower your daily independence. Consulting an experienced cataract surgery doctor in India connects you with world-class ophthalmologists using state-of-the-art lens technologies. Learn about the progressive symptoms, innovative surg
May 30, 2026

Experiencing blurry or cloudy vision due to aging can significantly lower your daily independence. Consulting an experienced cataract surgery doctor in India connects you with world-class ophthalmologists using state-of-the-art lens technologies. Learn about the progressive symptoms, innovative surg
May 30, 2026
Explore effective obesity treatments in Jalpaiguri. Learn about lifestyle changes, medical interventions, and specialist care for a healthier you.
May 20, 2026